BioInnovation Institute (BII) is a Copenhagen-based life science innovation institute established in 2017 by the Novo Nordisk Foundation to accelerate the commercialization of scientific research. The organization supports early-stage startups and research projects developing solutions in areas such as biotechnology, therapeutics, health technologies, and bio-industrial production. Through programs such as Venture Lab, Bio Studio, and Deep Tech Lab, BII provides funding, lab infrastructure, mentorship, and business development support to help translate scientific discoveries into venture-backed companies addressing challenges in human and planetary health.
Asset class
Impact theme
Investment geographies
Novo Holdings